Piper Sandler Reiterates Overweight on Indivior, Raises Price Target to $16

Benzinga · 10/25 14:50
Piper Sandler analyst David Amsellem reiterates Indivior (NASDAQ:INDV) with a Overweight and raises the price target from $15 to $16.